Non-interventional Observational and Nationwide French Study on Real-life Enfortumab Vedotin Outcomes as First-line Urothelial Carcinoma Treatment First published 12/11/2025 Last updated 01/10/2026 EU PAS number:EUPAS1000000763 Study Ongoing